THAT ARALLELUUMUTIUS009790237B2 (12 ) United States Patent ( 10 ) Patent No

THAT ARALLELUUMUTIUS009790237B2 (12 ) United States Patent ( 10 ) Patent No

THAT ARALLELUUMUTIUS009790237B2 (12 ) United States Patent ( 10 ) Patent No. : US 9 , 790 ,237 B2 Coughlin et al. (45 ) Date of Patent: Oct. 17 , 2017 (54 ) PROCESSES FOR MAKING ALKYLATED 403/ 12 ( 2013. 01 ) ; C07D 413/ 04 (2013 . 01 ) ; ARYLPIPERAZINE AND ALKYLATED C07D 413 / 12 ( 2013 . 01 ) ; C07D 417 /08 ARYLPIPERIDINE COMPOUNDS ( 2013 .01 ) ; C07D 417 / 12 ( 2013 .01 ) ; C07D INCLUDING NOVEL INTERMEDIATES 471/ 12 ( 2013 .01 ) ; C07D 487 / 12 (2013 .01 ) (58 ) Field of Classification Search (71 ) Applicant: Johnson Matthey Public Limited None Company , London (GB ) See application file for complete search history . (72 ) Inventors : Daniel J . Coughlin , Mullica Hill, NJ (US ) ; Jeremy C . Wilt , Marlborough , MA (US ) ; Da -Ming Gou , Burlington , (56 ) References Cited MA (US ) ; Steven Collier , Devens , MA (US ) U . S . PATENT DOCUMENTS 5 , 153 ,206 A 10 / 1992 Nagel ( 73) Assignee : Johnson Matthey Public Limited 5 , 159 , 100 A 10 / 1992 Hanselmann Company , London (GB ) ( Continued ) ( * ) Notice : Subject to any disclaimer, the term of this patent is extended or adjusted under 35 FOREIGN PATENT DOCUMENTS U . S . C . 154 ( b ) by 0 days. DE 967826 12 / 1957 WO 2011136383 A1 11 /2011 ( 21 ) Appl . No . : 14 /737 , 599 (Continued ) (22 ) Filed : Jun . 12 , 2015 OTHER PUBLICATIONS (65 ) Prior Publication Data Cherbuliez et al. , “ 148 . Recherches sur la Formation et la Trans US 2015 /0361099 A1 Dec . 17 , 2015 formation des esters LXXV [ 1 ] ” , Helvetica Chimica Acta , 1967 (50 ) pp . 1440 - 1452 ( English Summary Included ). Related U . S . Application Data (Continued ) (60 ) Provisional application No . 62 /012 ,701 , filed on Jun . 16 , 2014 . Primary Examiner - Emily Bernhardt (51 ) Int. Cl. ( 74 ) Attorney, Agent, or Firm — Shanay M . McCastle C07D 417 / 12 ( 2006 .01 ) C07D 209/ 56 ( 2006 .01 ) C07D 215 /227 ( 2006 .01 ) (57 ) ABSTRACT CO7D 261/ 20 ( 2006 .01 ) C07D 401 / 12 ( 2006 .01 ) Novel processes, and intermediates , for making alkylated CO7D 403 / 12 ( 2006 . 01 ) arylpiperazine and alkylated arylpiperidine compounds of C070 413 / 12 ( 2006 .01 ) the general formulas ( I ) and ( VII ) , respectively CO7D 519 /00 ( 2006 .01 ) CO7D 417 / 08 ( 2006 .01 ) C07D 275 /06 ( 2006 .01 ) e C07D 311/ 20 ( 2006 . 01 ) C070 311 / 06 ( 2006 . 01 ) On N N - Ar , C07D 215 / 22 ( 2006 .01 ) CO7D 413 / 04 ( 2006 . 01 ) C07D 239 /88 ( 2006 . 01 ) R1 R2 C07D 241/ 04 ( 2006 .01 ) ( VII ) C070 471/ 12 ( 2006 .01 ) C07D 48 7 / 12 ( 2006 . 01 ) - Ar C07D 209 /52 ( 2006 .01 ) C07C 39 /00 ( 2006 .01 ) Ri R2 ( Continued ) ( 52 ) U . S . CI. CPC .. .. .. .. CO7D 519 /00 (2013 . 01 ) ; C07C 39 / 00 wherein , R , and R , are individually selected from hydrogen , ( 2013 .01 ) ; C070 209 / 52 ( 2013 .01 ) ; C07D alkyl , substituted or alkyl; n = 0 , 1 , or 2 ; Y = NR3R4, OR5, or 209 / 56 ( 2013 .01 ) ; C070 215 /22 ( 2013 . 01 ) ; SR5, where Rz and R4 are individually selected from acyl or CO7D 215 /227 ( 2013 .01 ) ; CO7D 239 /88 sulfonyl , and where R , is aryl or heteroaryl, or heterocyclic ; (2013 .01 ) ; C07D 241 /04 (2013 . 01 ) ; C07D and Ar is an aryl , heteroaryl, or heterocyclic compound . 261/ 20 (2013 .01 ) ; C07D 275 / 06 ( 2013 .01 ) ; CO7D 311 /06 ( 2013 . 01 ) ; CO7D 311 / 20 (2013 .01 ) ; C07D 401/ 12 ( 2013 .01 ) ; C07D 1 Claim , No Drawings US 9 ,790 , 237 B2 Page 2 (51 ) Int . Cl. WO 2012123858 AL 9 /2012 CO7D 295 / 135 WO 2012131606 AL 10 / 2012 ( 2006 .01 ) WO 2012158492 A2 11 /2012 CO7D 409 / 12 ( 2006 .01 ) wo 2013014665 Al 1 / 2013 C070 471/ 08 ( 2006 .01 ) wo 2013014665 AL 2 /2013 WO 2013030722 Al 3 / 2013 ( 56 ) References Cited U . S . PATENT DOCUMENTS OTHER PUBLICATIONS 5 ,294 ,619 A 3 / 1994 Nagel Dolenski et al. , “ Molecules Amphiphiles Electroreductibles . Etude 5 , 532 , 372 A 7 / 1996 Saji et al. de la Reductio en Milieux de Sulfates d 'omega - ( 4 6 , 467 , 121 B110 / 2002 Franzino et al . 7 , 276 , 610 B2 10 / 2007 Huang et al . acetylphenoxy ) alkyle ” , Bull . Soc. Chim . Fr. 1996 ( 133 ) pp . 235 - 242 7 ,605 , 260 B2 10 /2009 Kakiya et al. ( English Summary Included ) . 8, 258 , 139 B2 9 / 2012 Ikeda et al . Nagamura et al. , “ Novel effect of Man -Made Molecular Assemblies 8 , 258 , 304 B29 / 2012 Meerpoel et al . on Photoinduced Charge Separation . 4 .Synthetic Bilayer Membrane 8 , 283 , 352 B2 10 / 2012 Otoda et al. of Amphipathic Viologen as an Efficient Electron Collector in 8 , 377 , 995 B2 2 / 2013 Ikeda et al. Photosensitized Redox Reactions " , Ber. Bunsenges . Phys. Chem . 2006 / 0025422 AL 2 / 2006 Nakamura et al . 1983 ( 87 ) 12 pp . 1129 - 1133 . 2006 /0257987 A1 * 11/ 2006 Gonzalez Jia et al. , “ Synthesis and Evaluation of a Novel Class Hsp90 Valcarcel A61K 31 /095 Inhibitors Containing 1 - phenylpiperazine Scaffold ” , Bioorganic & 435 / 188 Med . Chem . Letters 2014 ( 24 )6 pp . 1557 - 1561. 2007 /0160537 AL 7 /2007 Ishiyama Pai et al ., “ Synthesis of Novel Analogs 3 , 4 -dihydro -1H -luinolin 2008/ 0045543 A1 2 / 2008 Carter et al . 2 -one Derivatives as Typical Antidepressant, Sedative and Anti 2009 / 0076027 Al 3 / 2009 Czarnik Parksinson Agents ” , Heterocyclic Letters 2012 ( 2 ) 1 pp . 117 - 128 . 2009 /0176800 Al 7 / 2009 Ishiyama 2011/ 0237602 AL 9 /2011 Meltzer et al . Fischer et al. , “ Reaktivitaet and Toxizitaet Cyclischer 2011/ 0263847 A1 10 / 2011 Ae et al. Schwefelsaeur Fester” , Journal Fuer Praktische Chemie 1975 2011/ 0263848 A1 10 /2011 Ae et al . ( 317 ) 6 pp . 943 - 952 ( English Abstract Included ) . 2013 / 0018056 AL 1/ 2013 Ikeda et al. Lichtenberger, et al. , “ No 204 . Sur Les Sulfates de Diols ” , Bull . Soc . Chim . Fr. 1948 pp . 1002 - 1012 (English Abstract Included ) . Hassner et al. , “ El- Massenspektrometrie N -monosulfoalkyl FOREIGN PATENT DOCUMENTS substituierte Cyanine ” , Zeitschrift Fur Chemie 1989 (29 ) 2 pp . 65 -66 WO 2011136384 Al 11/ 2011 ( English Translated Included ) . WO 2012063246 AL 5 / 2012 WO 2012107890 A2 8 / 2012 * cited by examiner US 9 , 790 ,237 B2 2 PROCESSES FOR MAKING ALKYLATED ARYLPIPERAZINE AND ALKYLATED ARYLPIPERIDINE COMPOUNDS INCLUDING NOVEL INTERMEDIATES - N N — Ar CROSS -REFERENCE TO RELATED RiR2 APPLICATIONS (VII ) This application claimspriority of U . S . Provisional Patent Application No . 62 /012 ,701 , filed Jun . 16 , 2014, the disclo - 10 sures of which are incorporated herein by reference in their entireties for all purposes . R R2 FIELD OF THE INVENTION 15 wherein , R and R are individually selected from hydrogen , The present disclosure provides processes for making unsubstituted alkyl, and substituted alkyl, or R , and R , are alkylated arylpiperazine and alkylated arylpiperidine com - connected to form a 5 to 8 carbon cyclic ring ; n is 0 , 1 , or pounds as well as novel intermediate compounds formed 2 ; Y is NR3R4, ORs, or SR5, where Rz and R4 are individu during those processes. ally selected from acyl or sulfonyl, wherein Rz and R4 may 20 be connected to form a substituted or unsubstituted cyclic or BACKGROUND OF THE INVENTION bicyclic ring , and wherein R , is aryl or heteroaryl, or heterocyclic ; and Ar is an aryl or heteroaryl group . The piperazines are a broad class of chemical compounds, Novel intermediate compounds, made during the pro manym with important pharmacological properties, which contain a core piperazine functional group . Many currently 25 cesses described and claimed herein , are also disclosed . notable pharmaceutical drugs contain a piperazine ring as BRIEF DESCRIPTION OF THE DRAWINGS part of their molecular structure . Examples include : anti anginals (ranolazine , trimetazidine ) ; antidepressants ( amox apine , befuraline , buspirone , flesinoxan , gepirone , ipsa No drawings . pirone , nefazodone , piberaline , tandospirone , trazodone , 30 DETAILED DESCRIPTION OF THE vilazodone , zalospirone ) ; antihistamines (buclizine , INVENTION meclozine , cinnarizine , cyclizine , hydroxyzine , cetirizine , levocetirizine , niaprazine ) ; antipsychotics (fluphenazine , perphenazine, trifluoperazine , prochlorperazine, thiothix Definitions ene , flupentixol, zuclopenthixol, amperozide , aripiprazole , 35 Unless otherwise stated , the following terms used in this lurasidone , clozapine , olanzapine, perospirone, ziprasi application , including the specification and claims, have the done ); urologicals ( sildenafil, vardenafil) . definitions given below . It must be noted that, as used in the Piperidine is also widely used building block and chemi- specspecification and the appended claims, the singular forms cal reagent in the synthesis of organic compounds, including " a " , " an , " and " the " include plural referents unless the pharmaceuticals . Similar to piperazine , piperidine and its 40 context clearly dictates otherwise . derivatives are ubiquitous building blocks in the synthesis of All numerical designations , such as , weight, pH , tempera pharmaceuticals and fine chemicals . For example , the pip - ture , time, concentration , and molecular weight, including eridine structure is found in the following classes of phar - ranges , are approximations which are varied by 10 % . It is to maceuticals : SSRI ( selective serotonin reuptake inhibitors ) be understood , although not always explicitly stated , that all (paroxetine ) ; analeptics/ nootropics ( stimulants ) (methyl - 45 numerical designations are preceded by the term “ about. ” It phenidate , ethylphenidate , pipradrol, desoxypipradrol) ; also is to be understood , although not always explicitly SERM (selective estrogen receptor modulators ) ( ralox - stated , that the reagents described herein are merely exem

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    16 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us